Karen Fallen is the founder of Touchlight Genetics. Touchlight Genetics has raised $125M in total funding. Latest round: Series C.
Karen Fallen is the Chief Executive Officer of Touchlight Genetics, a synthetic DNA producer for genetic medicines. She was appointed CEO of Touchlight DNA Services, overseeing the company's operations in the U.K. Her leadership focuses on expanding manufacturing capabilities and advancing gene therapy technology.
Full founder directory · Investor directory · Company funding database · Fundraising library